Impact Ethics (@impactethics.bsky.social)

CASGEVY: Rethinking Drug Costs Through the Lens of Public Access Maria Klimenko considers the extent to which the price of innovative treatments like CASGEVY, a type of gene therapy, should reflect not just the cost of development, but also their broader societa… https://wp.me/p38o3S-1QO